Cargando…
Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies
Myelodysplastic syndrome (MDS) is a group of clonal hematopoietic disorders related to hematopoietic stem and progenitor cell dysfunction. However, therapies that are currently used to target hematopoietic stem cells are not effective. These therapies are able to slow the evolution toward acute myel...
Autores principales: | Chen, Xiaofang, Li, Ningyu, Weng, Jianyu, Du, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905046/ https://www.ncbi.nlm.nih.gov/pubmed/33644035 http://dx.doi.org/10.3389/fcell.2020.617466 |
Ejemplares similares
-
Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies
por: Liu, Jing, et al.
Publicado: (2020) -
Heat Shock Alters Mesenchymal Stem Cell Identity and Induces Premature Senescence
por: Shimoni, Chen, et al.
Publicado: (2020) -
Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges
por: Zhou, Xueke, et al.
Publicado: (2020) -
Editorial: Mesenchymal Stem Cell Senescence and Rejuvenation
por: Zhang, Yuelin, et al.
Publicado: (2021) -
Role of Hyperglycemia in the Senescence of Mesenchymal Stem Cells
por: Yin, Min, et al.
Publicado: (2021)